Compare Nuwellis Inc (NUWE) vs Stellantis N.V. Common Shares (STLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Stellantis N.V. Common Shares — how do they compare? Nuwellis Inc trades at $0.55 (market cap $2.00M), while Stellantis N.V. Common Shares trades at $4.31 (market cap $16.51B). The key difference: Stellantis N.V. Common Shares is far larger — about 8255× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (172,259 versus 28,274,156). Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 27 Days and Stellantis N.V. Common Shares for 0 Days on average.
| NUWE | STLA | |
|---|---|---|
Market Cap | $2.00M | $16.51B |
Volume | 172,259 | 28,274,156 |
Sector | Health | Consumer Cyclical |
52-Week High | $146.65 | $12.12 |
52-Week Low | $0.53 | $4.27 |
Typical Hold Time | 27 Days | 0 Days |
Enterprise Value | -$1.72M | $36.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.621, down 7.35% today, with a bearish technical signal despite oversold RSI readings. The company shows revenue growth with 2026 revenue reaching $9M, but continues to post significant losses with a -125.63% net income margin. Recent positive developments include strong Aquadex console adoption and expanded pediatric footprint, though cash flow remains negative requiring ongoing financing.
The outlook remains challenging with persistent losses and negative cash flow offset by promising commercial momentum. Investment opportunity hinges on the company's ability to achieve profitability while risks include execution challenges and dependence on financing. Analyst sentiment is mixed with equal buy/hold ratings reflecting the high-risk, high-reward nature of this medical technology stock.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Stellantis N.V. Common Shares
Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.
Read more on STLA →
